Advanced Biomedical Technologies Inc. Stock Analysis ABMT
United States Health Care Nano Cap Advanced BioMedical Technologies, Inc. engages in the business of designing, developing, manufacturing, and marketing biomaterial internal fixation devices. The company is headquartered in New York City, New York. The company went IPO on 2007-09-10. The Company’s primary products include Polymer Osteosynthesis Devices made of a proprietary material compositing of polyamide 6 (PA6), hydroxyapatite (HA) and poly (methyl methacrylate-co-N-vinylpyrrolidone) (P(MMA-co-NVP)). These advanced materials are used in surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, and reconstructive dental procedures. Its PA Binding Wires are under clinical trials and its PA Mini-Screws are under animal test.
Read More Advanced Biomedical Technologies Inc (ABMT) Chart
Key Statistics of Advanced Biomedical Technologies Inc (ABMT)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
100.00P/E Ratio (TTM)
-52 Week Range
Market Cap
40.00KAvg. Volume
100.00Dividend Yield
-Financial Metrics & Statements of Advanced Biomedical Technologies Inc (ABMT)
FAQ's for Advanced Biomedical Technologies Inc (ABMT)
- According to Musaffa’s Shariah screening methodology, Advanced Biomedical Technologies Inc (ABMT) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.